Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135355 · ClinicalTrials.gov registry record
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 26
- Enrollment target
NCT01135355: Clinical Trial study, sponsored by Stanford University.
NCT01135355 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01135355 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01135355
The ClinicalTrials.gov registry entry for NCT01135355 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01135355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01135355 about?
NCT01135355 is a clinical study titled "Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients". The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and i...
What is the current status of trial NCT01135355?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2008-07. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT01135355?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.